150
Participants
Start Date
June 30, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Basal therapy
Group A was treated with basal therapy including drugs such as interleukin-11, Ricocin, and Epsilon, and was administered until the PLT was ≥75×109/L.
rhTPO combined with Heptabopa treatment(group B)
In group B, they were treated with rhTPO and Heptabopa, and were medicated until their PLT was ≥75×109/L.
rhTPO combined with Heptabopa treatment(group C)
Ctit patients with platelet counts \<50×109/L were included in group C. All were treated with rhTPO and hypertrombopa and medicated until PLT ≥75×109/L.
Jinhua Central Hospital
OTHER